205 related articles for article (PubMed ID: 32299261)
1. Sarcopenia in chronic liver diseases: a translational overview.
Barbero-Becerra VJ; López-Méndez I; Romo-Araiza A; Visag-Castillo V; Chávez-Tapia NC; Uribe M; Juárez-Hernandez E
Expert Rev Gastroenterol Hepatol; 2020 May; 14(5):355-366. PubMed ID: 32299261
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia and chronic liver diseases.
Hsu CS; Kao JH
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
[TBL] [Abstract][Full Text] [Related]
3. Cause and management of muscle wasting in chronic liver disease.
Dasarathy S
Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia in cirrhosis: from pathogenesis to interventions.
Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia in Patients with Advanced Liver Disease.
Ponziani FR; Gasbarrini A
Curr Protein Pept Sci; 2018; 19(7):681-691. PubMed ID: 28462693
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge.
Kamimura H; Sato T; Natsui K; Kobayashi T; Yoshida T; Kamimura K; Tsuchiya A; Murayama T; Yokoyama J; Kawai H; Takamura M; Terai S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572604
[TBL] [Abstract][Full Text] [Related]
7. [Research advances of sarcopenia in chronic liver disease].
Xiao HJ; Zhang M; Qi YM; Han T
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):563-566. PubMed ID: 31357787
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications.
Fernández-Mincone T; Contreras-Briceño F; Espinosa-Ramírez M; García-Valdés P; López-Fuenzalida A; Riquelme A; Arab JP; Cabrera D; Arrese M; Barrera F
Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1141-1157. PubMed ID: 32811209
[TBL] [Abstract][Full Text] [Related]
9. Understanding of sarcopenia: from definition to therapeutic strategies.
Kim JW; Kim R; Choi H; Lee SJ; Bae GU
Arch Pharm Res; 2021 Oct; 44(9-10):876-889. PubMed ID: 34537916
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
Wang CW; Feng S; Covinsky KE; Hayssen H; Zhou LQ; Yeh BM; Lai JC
Transplantation; 2016 Aug; 100(8):1692-8. PubMed ID: 27314169
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia and liver transplant: The relevance of too little muscle mass.
Kallwitz ER
World J Gastroenterol; 2015 Oct; 21(39):10982-93. PubMed ID: 26494955
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of sarcopenia assessment in patients with liver cirrhosis.
Marasco G; Dajti E; Ravaioli F; Brocchi S; Rossini B; Alemanni LV; Peta G; Bartalena L; Golfieri R; Festi D; Colecchia A; Renzulli M
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):377-388. PubMed ID: 33196344
[No Abstract] [Full Text] [Related]
13. Mitochondrial transplantation as a possible therapeutic option for sarcopenia.
Turkel I; Ozerklig B; Yılmaz M; Ulger O; Kubat GB; Tuncer M
J Mol Med (Berl); 2023 Jun; 101(6):645-669. PubMed ID: 37209146
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.
Ohashi K; Ishikawa T; Imai M; Suzuki M; Hoshii A; Abe H; Koyama F; Nakano T; Ueki A; Noguchi H; Hasegawa E; Hirosawa S; Kobayashi M; Hirosawa H; Sato K; Munakata M; Yoshida T
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1408-1413. PubMed ID: 30964810
[TBL] [Abstract][Full Text] [Related]
15. Myostatin and sarcopenia: opportunities and challenges - a mini-review.
White TA; LeBrasseur NK
Gerontology; 2014; 60(4):289-93. PubMed ID: 24457615
[TBL] [Abstract][Full Text] [Related]
16. [Transdisciplinary Approach for Sarcopenia. Clinical significance of sarcopenia in the patients with chronic liver disease].
Shirabe K; Harimoto N; Ikegami T; Yoshizumi T; Itoh S; Takeishi K; Toshima T; Kimura K; Matsumoto Y; Bekki Y; Imai D; Yamashita Y; Kawanaka H; Maehara Y
Clin Calcium; 2014 Oct; 24(10):1493-9. PubMed ID: 25266095
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.
Harimoto N; Yoshizumi T; Izumi T; Motomura T; Harada N; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Nishie A; Kamishima T; Kusaba R; Shirabe K; Maehara Y
Transplant Proc; 2017 Nov; 49(9):2144-2152. PubMed ID: 29149975
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia: Etiology, Nutritional Approaches, and miRNAs.
Cannataro R; Carbone L; Petro JL; Cione E; Vargas S; Angulo H; Forero DA; Odriozola-Martínez A; Kreider RB; Bonilla DA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575884
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia.
Ticinesi A; Nouvenne A; Cerundolo N; Catania P; Prati B; Tana C; Meschi T
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31319564
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia in end-stage liver disease and after liver transplantation.
Leunis S; Vandecruys M; Van Craenenbroeck AH; Cornelissen V; Bogaerts S; De Smet S; Monbaliu D
Acta Gastroenterol Belg; 2023; 86(2):323-334. PubMed ID: 37428166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
